Harmony Biosciences Holdings (HRMY) Assets (2019 - 2026)
Harmony Biosciences Holdings (HRMY) posted Assets of $1.3 billion for Q1 2026, little changed sequentially from $1.3 billion in Q4 2025, and up 20.49% YoY from $1.1 billion in Q1 2025.
Harmony Biosciences Holdings (HRMY) Assets (2019 - 2026) Analysis & Trends
Harmony Biosciences Holdings has reported Assets for 8 years, with the latest figure at $1.3 billion in Q1 2026.
- Quarterly Assets rose 20.49% year-over-year to $1.3 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.3 billion (up 20.49% YoY) and the FY2025 annual result came in at $1.3 billion, up 27.26% from the prior year.
- Assets held at $1.3 billion in Q1 2026 per HRMY's latest filing, from $1.3 billion in the prior quarter.
- Over five years, Assets peaked at $1.3 billion in Q1 2026 and troughed at $464.0 million in Q1 2022.
- A 5-year average of $876.4 million and a median of $847.0 million in 2024 frame the typical range for Assets.
- The sharpest annual moves came in 2022 and 2024: Assets jumped 64.53% in 2022, then gained 12.92% in 2024.
- Over 5 years, Assets stood at $673.9 million in 2022, then grew by 20.42% to $811.4 million in 2023, then rose by 23.14% to $999.2 million in 2024, then gained by 27.26% to $1.3 billion in 2025, then gained by 0.02% to $1.3 billion in 2026.
- According to Business Quant data, Assets over the past three periods registered $1.3 billion, $1.3 billion, and $1.2 billion for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 27.42 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 41.73 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 10.03 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 4.32 Bn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 9.18 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 15.59 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 19.82 Bn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 5.56 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 2.10 Bn |
| 10 | Harmony Biosciences Holdings | 2.22 Bn | 1.41 Bn | 198.08 Mn | 1.37 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.37 Bn |
| Mar 31, 2026 | 1.27 Bn |
| Dec 31, 2025 | 1.27 Bn |
| Sep 30, 2025 | 1.21 Bn |
| Jun 30, 2025 | 1.11 Bn |
| Mar 31, 2025 | 1.06 Bn |
| Dec 31, 2024 | 999.20 Mn |
| Sep 30, 2024 | 928.14 Mn |
| Jun 30, 2024 | 858.38 Mn |
| Mar 31, 2024 | 846.99 Mn |
| Dec 31, 2023 | 811.45 Mn |
| Sep 30, 2023 | 777.77 Mn |
| Jun 30, 2023 | 760.18 Mn |
| Mar 31, 2023 | 715.09 Mn |
| Dec 31, 2022 | 673.87 Mn |
| Sep 30, 2022 | 643.46 Mn |
| Jun 30, 2022 | 505.03 Mn |
| Mar 31, 2022 | 464.01 Mn |
| Dec 31, 2021 | 433.44 Mn |
| Sep 30, 2021 | 391.09 Mn |